Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Results 131 - 140 of 210 for 3SBio. (0.10 seconds)

Shanghai Pharma is seeking to acquire a mid-sized US or...
Shanghai Duyiwei Biotechnology, a subsidiary of Gansu...
Abcam will pay $170 million to buy Epitomics, a US mAb...
China plans to spend $11.8 billion to increase biopharma...
Hangzhou Tigermed Consulting, a clinical-stage CRO,...
WuXi AppTec and MedImmune, an AstraZeneca subsidiary,...
Cardinal Health, a US drug distributor, spent $120...
Syros Pharmaceuticals of Boston raised $30 million to...
Shanghai Fosun Pharma, Chindex and a private equity...
Zhejiang Hisun Pharma contributed 75 drug products to...
prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | next
Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here